VOYA Investment Management Portfolio holdings
AUM
$100B
1-Year Return
30.07%
This Quarter Return
-14.67%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$39.6B
AUM Growth
-$8.6B
(-18%)
Cap. Flow
-$402M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
21.58%
Holding
2,992
New
341
Increased
841
Reduced
1,284
Closed
226
Top Buys
| 1 |
Visa
V
|
+$340M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$290M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$245M |
| 4 |
Humana
HUM
|
+$223M |
| 5 |
Estee Lauder
EL
|
+$170M |
Top Sells
| 1 |
O'Reilly Automotive
ORLY
|
+$189M |
| 2 |
Eli Lilly
LLY
|
+$177M |
| 3 |
Zebra Technologies
ZBRA
|
+$165M |
| 4 |
CDW
CDW
|
+$143M |
| 5 |
Qualcomm
QCOM
|
+$143M |
Sector Composition
| 1 | Technology | 24.12% |
| 2 | Healthcare | 14.6% |
| 3 | Financials | 10.79% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTRA
2001
DELISTED
Proterra Inc. Common Stock
PTRA
| $384K | ﹤0.01% |
+82,723
| New | +$384K |
|
|
TSP
2002
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $383K | ﹤0.01% |
+52,971
| New | +$383K |
|
2003
CCC Intelligent Solutions
CCCS
$6.32B
| $382K | ﹤0.01% |
+41,475
| New | +$382K |
|
2004
Future Fuel
FF
$172M
| $380K | ﹤0.01% |
52,182
+39,602
| +315% | +$288K |
|
2005
Flushing Financial
FFIC
$472M
| $380K | ﹤0.01% |
17,845
| – | – |
|
2006
iRobot
IRBT
$115M
| $379K | ﹤0.01% |
10,321
-365
| -3% | -$13.4K |
|
2007
WideOpenWest
WOW
$440M
| $379K | ﹤0.01% |
20,826
-1,316
| -6% | -$23.9K |
|
|
MODN
2008
DELISTED
MODEL N, INC.
MODN
| $379K | ﹤0.01% |
14,809
| – | – |
|
2009
BridgeBio Pharma
BBIO
$10.1B
| $378K | ﹤0.01% |
41,578
| – | – |
|
|
MRTX
2010
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $378K | ﹤0.01% |
5,633
-12,298
| -69% | -$825K |
|
2011
Krispy Kreme
DNUT
$527M
| $377K | ﹤0.01% |
+27,751
| New | +$377K |
|
2012
Energy Recovery
ERII
$769M
| $377K | ﹤0.01% |
19,424
+2,760
| +17% | +$53.6K |
|
2013
German American Bancorp
GABC
$1.53B
| $376K | ﹤0.01% |
11,002
| – | – |
|
2014
Cameco
CCJ
$34.9B
| $375K | ﹤0.01% |
17,897
-193
| -1% | -$4.04K |
|
2015
Prothena Corp
PRTA
$448M
| $375K | ﹤0.01% |
13,795
-500
| -3% | -$13.6K |
|
|
TVRD
2016
Tvardi Therapeutics, Inc. Common Stock
TVRD
$324M
| $375K | ﹤0.01% |
1,140
| – | – |
|
|
RVNC
2017
DELISTED
Revance Therapeutics, Inc.
RVNC
| $375K | ﹤0.01% |
27,154
-591
| -2% | -$8.16K |
|
2018
Veeco
VECO
$1.54B
| $374K | ﹤0.01% |
19,273
-646
| -3% | -$12.5K |
|
2019
Ginkgo Bioworks
DNA
$633M
| $373K | ﹤0.01% |
+3,917
| New | +$373K |
|
2020
American Well
AMWL
$107M
| $372K | ﹤0.01% |
4,309
+684
| +19% | +$59.1K |
|
2021
Enovis
ENOV
$1.79B
| $372K | ﹤0.01% |
6,761
-45,928
| -87% | -$2.53M |
|
2022
Entravision Communication
EVC
$218M
| $371K | ﹤0.01% |
81,349
+4,184
| +5% | +$19.1K |
|
|
PFC
2023
DELISTED
Premier Financial Corp. Common Stock
PFC
| $371K | ﹤0.01% |
14,643
| – | – |
|
|
FRG
2024
DELISTED
Franchise Group, Inc.
FRG
| $371K | ﹤0.01% |
10,585
-570
| -5% | -$20K |
|
2025
Caleres
CAL
$534M
| $370K | ﹤0.01% |
14,106
-867
| -6% | -$22.7K |
|